Obesity and In Vitro Fertilization.

Area of Science:

• Reproductive Endocrinology
• Obesity Medicine
• Assisted Reproductive Technology

Background:

• Obesity is a prevalent chronic disease affecting reproductive-age women.
• Established risks include ovulatory dysfunction, hormonal imbalances, and increased pregnancy complications.
• Limited data exists on pre-assisted reproductive technology (ART) weight loss interventions.

Approach:

• This review examines the impact of obesity on in vitro fertilization (IVF).
• It addresses differential treatment responses, access to care, and the efficacy of weight-reduction strategies.
• Known data on lifestyle, pharmacologic, and surgical interventions prior to IVF are outlined.

Key Points:

• Obesity affects IVF treatment response and outcomes.
• Weight loss strategies show mixed results in improving fertility.
• Optimal pre-IVF weight management approaches require further investigation.

Conclusions:

• Further research is crucial to determine the best weight loss strategies for infertile patients with obesity undergoing IVF.
• Personalized approaches considering lifestyle, medication, and surgical options may be necessary.
• Improving access to care and tailored interventions can enhance ART success rates.